21 Jan 2019 | 7:59 AM
 

Glenmark Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532296 | NSE Symbol: GLENMARK
642.05
-19.14
(-2.89 %)
18 Jan 2019 | 04:01 PM
Change company
  • Open (Rs)
    659.50
  • Prev. close (Rs.)
    661.20
  • High (Rs.)
    659.50
  • Low (Rs.)
    635.25
  • 52W H (Rs.)
    706.90
  • 52W L (Rs.)
    483.60
  • Volume
    39020
  • MCap (Rs in Cr.)
    18,116.60
642.1
-21.50
(-3.24 %)
  • Open (Rs)
    665.95
  • High (Rs)
    666.10
  • Low (Rs)
    637.25
  • Prev. close(Rs)
    663.60
  • Contracts Tra.
    21,85,000
  • Turnover (Cr.)
    141
  • Open Interest
    40,78,000
  • Open Int. chg
    2,34,000.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
28.49
Operating Margin (%)
17.80
Gross Profit Margin (%)
14.47
Net Profit Margin (%)
8.85
Total Debt/Equity
0.86
Dividend payout Ratio (Net Profit)
8.44
Earning Retention Ratio
91.56

News

08 Jan 2019 - 17:13:00-Glenmark Pharmaceuticals is targeting a consolidated revenue growth of up to 15 per cent over the ne...
20 Nov 2018 - 13:20:00-Glenmark Pharmaceuticals Tuesday said it has received approval from the US health regulator for Azel...
16 Nov 2018 - 14:29:00-Glenmark Pharmaceuticals Friday said it has received approval from the US health regulator for Terif...
09 Nov 2018 - 07:50:00-Glenmark Pharmaceuticals Thursday said it will launch phase 1 trial in solid tumors for its bispecif...

Announcements

18-Jan-2019
Glenmark Pharma - Statement Of Investor Complaints For The Quarter Ended December 2018
18-Jan-2019
Glenmark Pharma - Shareholding for the Period Ended December 31 2018
01-Jan-2019
Glenmark Pharma - Completion Of Transfer Of Company`s Active Pharmaceuticals Ingredient (API) Business.
10-Jan-2019
Glenmark Pharma - Press Release
10-Jan-2019
Glenmark Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release